TrialsgrambetaRCTs are beautiful

Ponticelli

1984

Ponticelli Regimen for Idiopathic Membranous Nephropathy

In 62 patients with idiopathic membranous nephropathy, alternating monthly methylprednisolone and a cytotoxic agent increased remission of nephrotic syndrome compared with supportive care.

Result

Complete or partial remission of nephrotic syndrome
Absolute difference
42 points
NNT
3

Absolute difference and NNT are derived from the event rates.

Original publication
Subtopic
Membranous nephropathy
Design
RCT, mean 31-month follow-up
Relevance
Supporting: context rather than must-know.
Source
Ponticelli C, et al. N Engl J Med. 1984;310(15):946-950.doi 10.1056/NEJM198404123101503

Discussion & critique

A decades-long first-line cytotoxic regimen for progressive membranous nephropathy; its toxicity drove the search for rituximab alternatives.